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ABSTRACT. Background and aims: The relative
weight of various etiologies of dementia and mild cog-
nitive impairment (MCI) as predictors of intra-hospital,
short- and long-term mortality in very old acutely ill pa-
tients suffering from multiple comorbid conditions
remains unclear. We investigated intra-hospital, 1-
and 5-year mortality risk associated with dementia
and its various etiologies in a very old population after
discharge from acute care. Methods: Prospective co-
hort study of 444 patients (mean age 85 years; 74% fe-
male) discharged from the acute geriatric unit of Gene-
va University Hospital. On admission, each subject
underwent standardized evaluation of cognitive and co-
morbid conditions. Patients were followed yearly by the
same team. Predictive variables were age, sex, cognitive
diagnosis, dementia etiology and severity. Survival
during hospitalization, at 1- and 5-year follow-ups
was the outcome of interest evaluated with Cox pro-
portional hazard models. Results: Two hundred and
six patients were cognitively normal, 48 had MCI,
and 190 had dementia: of these, there were 75 cases
of Alzheimer’s disease (AD), 20 of vascular dementia
(VaD), 82 of mixed dementia (MD) and 13 of other
types of dementia. The groups compared were statis-
tically similar in age, sex, education level and comor-
bidity score. After 5 years of follow-up, 60% of the pa-
tients had died. Regarding intra-hospital mortality,
none of the predictive variables was associated with
mortality. MCI, AD and MD were not predictive of
short- or long-term mortality. Features significantly as-
sociated with reduced survival at 1 and 5 years were be-
ing older, male, and having vascular or severe de-
mentia. When all the variables were added in the
multiple model, the dementia effect completely dis-
appeared. Conclusions: Dementia (all etiologies) is not
predictive of mortality. The observed VaD effect is
probably linked to cardiovascular risk comorbidities: hy-
pertension, stroke and hyperlipidemia.
(Aging Clin Exp Res 2011; 23: 60-66)
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INTRODUCTION
Dementia is a serious health problem with a signifi-
cant economic impact. Previous studies of population-
based cohort type have evaluated survival in relation to
dementia, most reporting that the risk of death is high-
er in the presence of dementia than in its absence (1-6).
A recent Danish population-based cohort study (14
years of follow-up) involving 3065 non-demented
(73.7±6.8 years) and 234 demented (83.3±7.0 years)
subjects at baseline, showed that the hazard ratio (HR)
of death increased from 1.82 for very mildly demented
to 9.52 for severely demented subjects (7). However,
most studies have analyzed mortality in patients with
cognitive impairment as a global diagnosis (7) or only in
patients with Alzheimer’s disease (AD) (3, 5). Only a few
rare studies have considered mortality in other types of
dementia, such as mixed dementia (AD plus vascular),
which is very frequent in the very old, or in mild cog-
nitive impairment (MCI) (8, 9). In addition, the non-de-
mented subjects in these studies are often significantly
younger (2, 3) and have significantly fewer comorbid
conditions than the group of demented patients. Also,
there are only a few studies examining short-term (1-
year) mortality and rare ones examining long-term (5-
year) mortality in acutely ill very old patients after dis-
charge from hospital, and information on the same
population remains scarce.
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We therefore studied the relationship between the
various etiologies and severities of dementia and MCI and
intra-hospital, short- and long-term mortality in a popu-
lation of very old, acutely ill patients discharged from a
geriatric hospital, in a prospective cohort study. We in-
vestigated the extent to which cognitive diagnosis was of
greater added prognostic value in a population having the
same number of other comorbid conditions.
METHODS
Patients and data collection
We carried out a prospective study in an acute 300-
bed geriatric hospital (HOGER), in which 22.7% of pa-
tients are admitted directly from the community, 54.0%
are referred by the emergency unit, and 23.3% are
transferred from other divisions of the university hospi-
tals of Geneva, Switzerland. The patients and data col-
lection have been described elsewhere (10, 11). Briefly,
a representative sample of all consecutive admissions of
patients aged 75 years and over in 2004 was selected by
randomization, with a sampling fraction of 30% and a
computer-generated randomization table. Exclusion cri-
teria were disorders interfering with psychometric as-
sessment (severe deafness or blindness, or major be-
havioral problems) and terminal illness. The local Ethics
Committee approved the protocol, and patients, their
families or legal representatives gave their signed in-
formed consent. Patients’ demographic data did not
significantly differ from that for all patients admitted to
HOGER over the same period. Our sample was therefore
representative of all patients admitted to this hospital,
demonstrating the reliability and quality of the random-
ization procedure used.
Medical history was recorded on a standardized form
and the same geriatrician carried out a comprehensive
geriatric assessment of all patients. Annual follow-up
was carried out by the same assessment procedure, over
a 5-year period.
Socio-demographic data
Data recorded included age, sex, native language,
marital status, living conditions and educational level
(1=≤11; 2=12-14; 3=≥15 years of schooling).
Cognitive diagnosis
The same neuropsychologist assessed all subjects for
clinical dementia, at least one week after admission, to
avoid the effects of concomitant delirium. The Mini-
Mental State Examination (MMSE) and the Short Cog-
nitive Evaluation Battery (12) were used. According to
screening results, the same neuropsychologist carried
out a comprehensive standardized neuropsychological
assessment, to determine the etiology and severity of
clinical dementia, as previously described (10, 11). Briefly,
the battery of neuropsychological tests included the fol-
lowing specific tests of cognitive function: the Mattis De-
mentia Rating Scale as a global scale; Buschke Double
Memory Test (16 or 48 items according to education lev-
el), which assesses episodic memory and provides cog-
nitive support for both encoding and retrieval, discrimi-
nating effectively between normal elderly subjects and sub-
jects with mild dementia; Trail-Making Test, which mea-
sures mental flexibility, and Verbal Fluency Test, which in-
vestigates verbal incitement, both these tests assessing ex-
ecutive function; Consortium to Establish a Registry for
Alzheimer’s Disease (CERAD) Figures, which measure vi-
suospatial and construction abilities; Lexis or Bachy test
for language, and Digit Symbol test for evaluating atten-
tion. Dementia severity was assessed on the Clinical De-
mentia Rating Scale (CDR) (13) [score 0.5 for MCI (14),
score 1 for mild, score 2 for moderate and score 3 for se-
vere dementia]. The formal clinical criteria used for diag-
nosis were those of the Diagnostic and Statistical Manual
of Mental Disorders, 4th ed., text revision (DSM IV-TR)
(15), the National Institute of Neurological and Commu-
nicative Diseases and Stroke/Alzheimer’s Disease and
Related Disorders Association (NINCDS-ADRDA) (16),
and the National Institute of Neurological Disorders and
Stroke – Association Internationale pour la Recherche
et l'Enseignement en Neuroscience (NINDS-AIREN) (17).
Brain imaging was also carried out and patients were
then assigned to one of three groups: a) normal cognition,
b) MCI, and c) dementia of various types: AD, vascular de-
mentia (VaD), mixed dementia (MD), degenerative and vas-
cular dementia in the same patient, and other types of de-
mentia.
Comorbidity
From our previous work on this cohort (18), the
best prognostic predictor of 5-year mortality was the
Geriatric Index of Comorbidity (GIC) (19), class 4 mul-
tiplying the risk of death by 4, so we used this comor-
bidity score in this study. The same geriatrician calculated
the score for each patient, via an extensive review of the
patient's medical records and administrative data for
diagnoses, established at or before enrolment in this
study and by standardized interviews with patients
and/or surrogates. In computing the GIC, each of the
15 most prevalent clinical conditions (ischemic or organic
heart disease, primary arrhythmias, heart disease with a
non-ischemic or organic origin, hypertension, stroke, pe-
ripheral vascular disease, diabetes mellitus, anemia,
gastro-intestinal disease, hepatobiliary disease, renal
disease, respiratory disease, parkinsonism and non-
vascular neurologic disease, musculoskeletal disorders,
malignancies) is graded on a 0 to 4 disease severity
scale, according to the following general framework: 0
= absence of disease, 1 = asymptomatic disease, 2 =
symptomatic disease requiring medication but under
satisfactory control, 3 = symptomatic disease uncon-
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trolled by therapy, and 4 = life-threatening or the most
severe form of the disease. The GIC classifies patients in-
to four classes of increasing somatic comorbidity. Class
1 comprises patients who have one or more condi-
tions with a disease severity grade ≤1, class 2 patients
who have one or more conditions with a disease sever-
ity grade of 2, class 3 patients who have one condition
with a disease severity of 3, other conditions having a
disease severity ≤2, and class 4 patients who have two
or more conditions with a disease severity of 3 or one or
more conditions with disease severity of 4. Only 2% of
patients were classified as class 1, allowing us to com-
bine classes 1 and 2 for purposes of analysis.
Outcomes
The outcomes of interest were intra-hospital mortal-
ity, death by December 31, 2005 for short-term mortality
(1-year mortality) and December 31, 2009 for long-
term mortality (5-year mortality). Information was ob-
tained by yearly assessment, telephone calls to the patient,
the patient’s family and/or the patient’s general practi-
tioner. Mortality data were confirmed by the data of the
population registry of the Canton of Geneva.
Statistical methods
We checked the normality of the data by carrying out
skewness and kurtosis tests. Data for continuous vari-
ables are presented as means ± 1 standard deviation
(SD). Kruskal-Wallis tests were performed to compare
the data for the following groups: cognitively normal pa-
tients, patients with MCI, and demented patients. We
first investigated the univariate relationship between
each independent variable and intra-hospital, 1-year
and 5-year mortality. We used Cox proportional hazards
models to take into account the time to the event. The
independent variables assessed as possible predictors in-
cluded age, sex, cognitive diagnosis (normal, MCI, or de-
mentia), dementia etiology (AD, VaD and MD; “other
dementia” was excluded from the analysis due to its het-
erogeneity and small size) and dementia severity treated
as a dichotomous variable (CDR 0.5-1 = mild; CDR 2-
3 = moderate to severe dementia). We then entered all
independent variables, together with intra-hospital, 1-
year and 5-year mortality as the dependent variable, in
multiple Cox models. The hazard proportional as-
sumption was respected for each regression. HR and
their 95% confidence intervals (CI) were calculated.
Pseudo R-squared (R2), which provides information
about the proportion of the variance explained by the
model, was computed with the Stata “str2ph” com-
mand, based on Royston's modification of O’Quigley, Xu
& Stare’s modification of Nagelkerke’s R2 statistic for
proportional hazards models with censored survival da-
ta. Statistical analyses were performed with Stata soft-
ware version 11.1, Texas, U.S.
RESULTS
Of the 444 patients studied (mean age 85.3±6.7;
74.0% women), 206 were cognitively normal, 48 had
MCI, and 190 had dementia: 75 cases of AD, 20 of
VaD, 82 of MD, and 13 of other types of dementia (3
cases of dementia with Lewy bodies, 3 of Parkinson’s
disease with dementia, 1 of Creutzfeld-Jacob disease, 1
of cortico-basal dementia, 3 of fronto-temporal de-
mentia, 1 of hydrocephaly with normal pressure, and 1
of alcohol-related dementia). Of the 444 patients, 22
(5%) died during hospitalization, 104 (23.4%) died dur-
ing the first year after discharge, and 263 died during the
5 years after discharge (59.2%); 115 were cognitively
normal (43.7%); 121 demented (46%) and 27 MCI
(10.3%), with similar proportions for each group (p
was not significant). Details are shown in Table 1.
The socio-demographic data and clinical features by
cognitive impairment diagnosis have been published pre-
viously (11) (Table 2). Briefly, the groups compared (cog-
nitively normal, MCI and demented) were similar in age,
sex and education level. Patients without dementia were
more likely to live alone (65%) than demented patients
(50% of patients with MCI or dementia); 8% of dement-
ed patients were living in a nursing home, whereas this
was the case for only 1% of non-demented patients.
The GIC scores were very high; the majority of patients
were assigned to GIC class 3 (n=310, 69.8%), followed by
class 4 (n=91, 20.5%) and classes 1-2 (n=43, 9.7%)
and GIC scores did not differ significantly between patients
with different cognitive status.
Patients in the VaD group tended to be younger and
were more likely to be male, although these trends were not
statistically significant. They had higher average comorbidity
scores, when compared with other demented patients,
more frequent hypertension, stroke and hyperlipidemia. Co-
morbidity did not increase with dementia severity.
Intra-hospital One year Five years
n % n % n %
Non-demented 12 54.5 39 37.5 115 43.7
MCI 3 13.6 10 9.6 27 10.3
Demented 7 31.9 55 52.9 121 46.0
AD 1 4.5 16 15.4 45 17.1
MD 5 22.7 27 26.0 50 19.0
VaD 1 4.5 7 6.7 17 6.5
Other types
of dementia 0 - 5 4.8 8 3.0
Total number
of deaths 22 100 104 100 263 100
MCI: mild cognitive impairment (14); AD: Alzheimer’s disease; MD: mixed
dementia; VaD: vascular dementia.
Table 1 - Number of intra-hospital deaths, after 1- and 5-year fol-
low-ups, according to cognitive impairment diagnosis.
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Univariate and multiple Cox proportional hazard
modeling (Table 3)
The following outcomes are shown in Table 3: intra-
hospital mortality, mortality 1 year after discharge and 5
years after discharge, including all the potentially predic-
tive variables tested: presence or absence of dementia, de-
mentia etiology and dementia severity.
For the three outcomes, mortality was significantly
Table 3 - Univariate Cox regression predicting intra-hospital, 1- and 5-year mortality (n=444).
Table 2 - Patients’ socio-demographic and clinical variables according to cognitive status.
Characteristics Cognitively normal (n=206) MCI (n=48) Demented (n=190) p-valuec
Agea 84.5 ±7.0 85.0 ±6.6 86.1 ±6.4 0.093
Femaleb 151 73.3% 40 83.3% 137 72.1% 0.278
Educational levela 0.408
1=≤11 years 123 59.7% 31 64.6% 103 54.2%
2=12-14 years 66 32.0% 10 20.8% 66 34.7%
3=≥15 years 17 8.3% 7 14.6% 21 11.1%
Living conditionsa 0.002
At home 204 99.0% 47 97.9% 175 92.1%
Nursing home 2 1.0% 1 2.1% 15 7.9%
GIC scorea 0.290
Classes 1 and 2 20 9.7% 5 10.4% 18 9.5%
Class 3 150 72.8% 35 72.9% 125 65.8%
Class 4 36 17.5% 8 16.7% 47 24.7%
Hypertensionb 145 70.4% 28 58.3% 130 68.4% 0.271
Ischemic heart diseaseb 54 32.0% 13 31.7% 41 25.8% 0.442
Diabetes mellitusb 43 20.9% 10 20.8% 32 16.8% 0.567
Strokeb 20 11.8% 4 9.8% 33 20.8% 0.047
Known dyslipidemiab 27 16.0% 7 17.1% 23 14.5% 0.889
aData are expressed as means±SD; bnumber of cases (%); cp-value, Kruskal-Wallis test. GIC score: Geriatric Index of Comorbidity (19). Entries in bold type:
significant results.
Intra-hospital One-year mortality Five-year mortality
Characteristics Crude 95% CI p Pseudo HR 95% CI p Pseudo HR 95% CI p Pseudo
HR R2 R2 R2
Agea 1.08 1.00-1.16 0.029 0.027 1.07 1.04-1.15 <0.001 0.115 1.07 1.05-1.09 ≤0.001 0.097
Male vs female 1.07 0.41-2.81 0.888 0.001 1.27 0.83-1.93 0.271 0.007 1.52 1.17-1.98 0.002 0.021
Demented vs normal 0.65 0.26-1.62 0.353 0.009 1.54 1.05-2.26 0.028 0.028 1.27 1.00-1.62 0.053 0.009
Demented vs
MCI vs normal 0.005 0.088 0.009
Normal 1.00 - - 1.00 - - 1.00 - -
MCI 1.08 0.29-3.99 0.904 1.07 0.54-2.16 0.836 0.99 0.65-1.50 0.904
Demented 0.66 0.25-1.71 0.389 1.56 1.04-2.35 0.033 1.27 0.98-1.64 0.068
Type of dementia 0.021 0.143 0.016
Normal 1.00 - - 1.00 - - 1.00 - -
MCI 1.08 0.29-3.99 0.904 1.08 0.54-2.16 0.832 0.99 0.65-1.51 0.962
AD 0.21 0.03-1.67 0.142 1.11 0.62-2.00 0.719 1.11 0.79-1.57 0.548
VaD 0.81 0.10-6.58 0.846 1.96 0.87-4.37 0.019 2.00 1.18-3.33 0.008
MD 1.06 0.36-3.09 0.360 1.80 1.10-2.94 0.102 1.22 0.87-1.70 0.247
Severity of dementia 0.005 0.018 0.015
Normal 1.00 - - 1.00 - - 1.00 - -
CDR 0.5-1 0.63 0.22-1.83 0.396 1.14 0.71-1.83 0.879 1.04 0.78-1.39 0.772
CDR 2-3 0.91 0.31-2.67 0.868 1.93 1.22-3.04 0.005 1.47 1.09-1.98 0.011
aNormalized by square root transformation. MCI: mild cognitive impairment (14); AD: Alzheimer’s disease; VaD: vascular dementia; MD: mixed dementia; 
CDR: Clinical Dementia Rate (13); HR: hazard ratio; CI: confidence interval. Entries in bold type: significant results.
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In our population of very old patients, the 5-year
mortality rate was almost 60% after discharge. This
rate is similar to that reported in previous studies. Age it-
self is a well-known negative prognostic risk factor for
death, and this factor accounted for almost 10% of the
variance of the outcome in this study in the univariate
model. In addition, in the multiple regression analysis, age
was the only remaining predictor for 1- and 5-year mor-
tality risk.
For intra-hospital mortality, dementia, independent
of etiology or severity, was not a predictor of death. Re-
cently, a retrospective study based on hospital discharge
database records in the period 1998-2003 from public
hospitals in Andalusia, Spain, identified 40,482 cases of
dementia, and reported that the intra-hospital mortality
rate was greater (19.3 vs 8.7%) for patients with de-
mentia compared with those without dementia. Demen-
tia was an independent predictor of mortality [odds ratio
(OR)=1.77; 95% CI=1.72-1.82] (21). This study was
conducted in general hospitals, all ages confounded. In an
Italian study of 923 patients at least 65 years old (mean
age 78.7±7.2, 49% women) admitted to the acute care
geriatric ward of an internal medicine department, in-hos-
pital mortality was independently predicted by lower
MMSE scores at hospital admission (OR=5.51, 2.34-
12.9) (22). More recently, a study conducted in Iceland
showed that moderate to severe cognitive problems pre-
dicted intra-hospital death but not death after 1 year of fol-
low-up in a population of 749 patients discharged from an
acute care hospital (23). In these studies, no complete sys-
tematic neuropsychological assessment was carried out,
patients were classified with cognitive impairment as a
global diagnosis, and etiology was not taken into ac-
count. In addition, the studied population was at least 10
years younger than ours.
In our study, MCI, AD and MD were not predictive of
short- or long-term mortality. In contrast, many studies
have investigated survival as a function of dementia, and
most have reported that the risk of death is higher in pa-
tients with dementia than in those without (3-9, 24-26).
Most of these studies were population-based and exam-
ined survival from the time of dementia diagnosis, where-
as our study, which was not designed for exactly the
same purpose, was based on a selected group in a clini-
cal setting and 42% of the cohort had already been di-
agnosed with dementia at baseline. In some of the above
studies, cognition was assessed with the MMSE alone. The
MMSE is neither sensitive nor specific for detecting de-
mentia in a very old population and, in addition, does not
distinguish between different types of dementia. One of
the main strengths of our study was its standardized
comprehensive assessment: the same neuropsychologist
carried out the same systematic, complete neuropsy-
chological assessment of all study patients, which in-
creased the accuracy of cognitive diagnosis and allowed us
associated with age, each additional year increasing the
risk of death by 7-8%. Being male increased the risk of
death by a factor of 1.5 only for 5-year mortality. For in-
tra-hospital mortality, none of the independent vari-
ables was a predictor of the outcome. For this reason, we
used only univariate models and not multiple models
for this outcome. Dementia was associated with a sig-
nificantly higher risk of 1-year death than not being de-
mented (p=0.028), increasing the risk by 50%, although
considering only the MCI group (p=0.033). This asso-
ciation disappeared when the outcome was the risk of 5-
year death. VaD was the only type of dementia signifi-
cantly associated with a double risk of death at 1- and 5-
year follow-ups. MCI, AD and MD were not predictive of
intra-hospital, short- or long-term mortality. Severely
demented patients (CDR 2-3; regardless of etiology)
had a 100% higher risk of dying than non-demented con-
trols when 1-year death was the outcome and a 50%
higher risk of dying when 5-year death was the out-
come.
The introduction of all variables into the full model elim-
inated the association of moderate and severe dementia
(HR=1.7, 95% CI=0.57-5.14, p=0.334) for 1-year and
(HR=1.2, 95% CI=0.61-2.27, p=0.619) for 5-year mor-
tality; particularly VaD: HR=1.3, 95% CI=0.44-4.02,
p=0.615 for 1-year and HR=1.7, 95% CI=0.86-3.30,
p=0.125 for 5-year mortality. Age remained significant-
ly associated with 1-year mortality (HR=1.07, 95%
CI=1.03-1.11, p<0.001), accounting for 12.5% of the
variability of this outcome. Age (HR=1.08, 95% CI=1.05-
1.10, p<0.001) and sex (HR=1.67, 95% CI=1.21-2.30,
p=0.002) remained significantly associated with 5-year
mortality, also accounting for 12.7% of the variability of
this outcome.  
DISCUSSION
This series of elderly inpatients (mean age 85 years)
was representative of the overall population of patients in
this geriatric hospital. The prevalence of dementia (43%)
was very high; the prevalence of dementia in elderly in-
patients (acute geriatric wards) has been reported to be be-
tween 20 and 30%. A previous study carried out in the
same hospital reported a prevalence of 30%. The differ-
ence between these two studies in the same hospital is sta-
tistically significant (p=<0.001) (20). These findings prob-
ably reflect the systematic and complete assessment of
cognitive impairment in the random sample used to de-
termine the prevalence of dementia. The inclusion of a
large number of patients with dementia in this study was
useful, as it was possible to measure the impact of de-
mentia on the outcomes of interest. In addition, comorbid
scores were  very high and similar in all three groups (cog-
nitively normal, demented, MCI) allowing comparisons and
then assessment of the influence of dementia among
other comorbidities. 
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to take the various etiologies and severity of dementia in-
to account. Our study was also unusual in its inclusion of
a group of patients with MCI in addition to the demented
and non-demented groups. These patients behaved more
like ones with normal cognition than demented patients.
In addition, the same geriatrician scored the presence and
extent of comorbidity in all patients.
In our study, features significantly associated with re-
duced survival at 1 and 5 years were being older, male,
and having vascular or severe dementia. This effect can
probably be explained by the higher average comorbidi-
ty scores in the VaD group compared with the AD and
MD groups, especially more likely to be diagnosed as hav-
ing cerebrovascular diseases such as stroke and cardio-
vascular risk factors like hypertension and high cholesterol.
The multiple analyses confirmed these results: when all the
variables were added in the multiple model, the effect of
dementia severity and VaD completely disappeared, con-
firming that dementia (all etiologies) is not predictive of
short- or long-term mortality, but the effect observed is
probably linked to cerebro- and cardiovascular comor-
bidites (hypertension, stroke and hyperlipidemia).
Nonetheless, in the literature, higher comorbidity and
poor functional status both had a negative effect on sur-
vival. Previous studies have also shown that poorer func-
tional status before and at the time of hospital admission
is associated with higher short- and long-term mortality
and higher comorbidity scores (27-30). 
Our study is subject to several limitations. First, as it fo-
cused on hospitalized elderly patients, it is difficult to
generalize the conclusions drawn to all subjects, whether
living in institutions or in the community. Second, this was
a single-center study, and there is therefore a need to con-
firm the results obtained in other centers. Third, the en-
rolled patients were very old, acutely ill, and had a high
burden of comorbidities.
In conclusion, we assessed intra-hospital, short-term
and long-term mortality in acutely ill very old patients, with
and without dementia. The groups with and without de-
mentia were of similar age and had similar levels of co-
morbidity. MCI, AD and MD were not predictive of intra-
hospital, short- or long-term mortality. Only VaD sig-
nificantly predicted 1- and 5-year mortality. The VaD
group had the highest comorbidity score. Comorbid
medical conditions should therefore be considered more
than cognitive impairment, when trying to predict in-
tra-hospital, short- and long-term survival in very old
medically ill inpatients. These findings have global impli-
cations for well-planned follow-up and home support af-
ter discharge, including medical and non-medical ser-
vices.
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